
Parytine 37.5mg Tablet CR
Marketer
Ryon Pharma
Salt Composition
Paroxetine (37.5mg)
Overview Parytine 37.5mg Tablet CR
Sertraline 37.5mg extended-release tablets are an antidepressant categorized as a selective serotonin reuptake inhibitor (SSRI). This medication is frequently used to manage depressive disorders and anxiety conditions such as obsessive-compulsive disorder and panic attacks. Sertraline 37.5mg extended-release tablets aid many in recovering from depression by improving mood and alleviating anxiety and tension. Administration is independent of food intake. Dosage and frequency are determined by your physician to optimize symptom control; initially, a lower dose may be prescribed, gradually increasing as needed. Never alter dosage or discontinue treatment without consulting your doctor, as this could worsen your condition or trigger unpleasant withdrawal effects (including anxiety, restlessness, palpitations, dizziness, sleep disturbances). For optimal results, take the medication consistently at the same time daily. Morning administration may be recommended if sleep disturbances occur. Significant improvement may take several weeks. Report lack of progress after four weeks to your physician. Common side effects include nausea, fatigue, dry mouth, decreased appetite, increased sweating, dizziness, nervousness, tremors, insomnia, and constipation. Reduced libido, delayed ejaculation, and erectile dysfunction are also possible. Immediately report any sudden mood worsening or suicidal ideation. Prior to commencing treatment, inform your physician of any epilepsy, diabetes, hepatic or renal impairment, cardiovascular disease, or glaucoma, as these conditions may influence treatment. Pregnant or breastfeeding individuals require physician consultation before use. Interactions may occur with other medications, especially other antidepressants and MAO inhibitors; fully disclose all current medications for safe usage.
Uses of Parytine 37.5mg Tablet CR
Managing Depressive Illnesses | Addressing Panic Attacks | Anxiety Disorder Therapies
Major Benefits of Parytine 37.5mg Tablet CR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Parytine 37.5mg Controlled-Release Tablets can be administered with or without food, although consistent timing is recommended.
Common Side effects of Parytine 37.5mg Tablet CR:
- Nausea
- Fatigue
- Dryness in mouth
- Loss of appetite
- Increased sweating
- Dizziness
- Nervousness
- Tremors
- Low sexual desire
- Insomnia (difficulty in sleeping)
- Confusion
- Constipation
- Erectile dysfunction
- Delayed ejaculation
- Decreased libido
How to use Parytine 37.5mg Tablet CR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Parytine 37.5mg Tablet CR whole; do not crush, chew, or divide it. While it can be taken with or without food, consistent timing is recommended.
How Parytine 37.5mg Tablet CR works:
Sertraline 37.5mg Controlled-Release tablets are an antidepressant medication classified as a selective serotonin reuptake inhibitor (SSRI). Their mechanism involves boosting serotonin, a neurotransmitter, within the brain. This elevation alleviates depressive symptoms, both emotional and physical, and also provides relief from panic attacks, anxiety, and obsessive-compulsive disorder.
SAFETY ADVICE
AlcoholUNSAFE
Combining Parytine 37.5mg Tablet CR and alcohol is inadvisable.
PregnancyUNSAFE
Use of Parytine 37.5mg Tablet CR is strongly contraindicated during pregnancy. Pregnant individuals should consult their physician; research in animals and pregnant women indicates substantial risk of harm to the fetus.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Parytine 37.5mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking a Parytine 37.5mg Controlled-Release tablet might reduce alertness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Parytine 37.5mg Tablet CR. A modified dosage of Parytine 37.5mg Tablet CR might be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use Parytine 37.5mg Controlled-Release tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Parytine 37.5mg Tablet CR :
Should you forget a Parytine 37.5mg Tablet CR dose, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Parytine 37.5mg Tablet CR
| Label | Value |
|---|---|
| Chemical Category | Phenylpiperidine analog |
| Developing Habits | No. |
| Treatment Category | Central Nervous System (CNS) Neurology |
| Action Class | Selective serotonin reuptake inhibitors (SSRIs) |
